FRT
45
-3
SO
53
-4
MUR
48
3
COF
59
-4
DOV
69
-4
AEE
60
-3
ORCL
68
-3
TSCO
49
-2
SYK
71
-2
ES
29
3
TSN
50
2
URBN
55
-11
NAVI
55
-2
AIZ
80
2
FLR
50
2
SRE
63
-3
AES
44
3
MMC
57
-7
DIS
68
6
CSX
62
-6
FRT
45
-3
SO
53
-4
MUR
48
3
COF
59
-4
DOV
69
-4
AEE
60
-3
ORCL
68
-3
TSCO
49
-2
SYK
71
-2
ES
29
3
TSN
50
2
URBN
55
-11
NAVI
55
-2
AIZ
80
2
FLR
50
2
SRE
63
-3
AES
44
3
MMC
57
-7
DIS
68
6
CSX
62
-6
Financhill
Back

Bioage Labs 10K Form

Sell
41

BIOA
Bioage Labs

Last Price:
18.28
Seasonality Move:
--

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BIOA News And Ratings

See the #1 stock for the next 7 days that we like better than BIOA

BIOA Financial Statistics

Sales & Book Value

Annual Sales: $14.94M
Cash Flow: $-15.82M
Price / Cash Flow: 0
Annual Sales: $-6.38
Price / Book: 0

Profitability

EPS (TTM): -1.77420
Net Income (TTM): $-54.84M
Gross Margin: $-7.38M
Return on Equity: 0%
Return on Assets: 0%

Bioage Labs Earnings Forecast

Key Bioage Labs Financial Ratios

  • The Gross Profit Margin over the past 5 years for BIOA is -49.40%.
  • The Selling, General & Administrative Expenses for BIOA have been equal to 95.65% of Gross Profit Margin.
  • The Interest Expense is -12.21% of Operating Income.
  • Per Share Earnings over the last 7 years have been positive in 3 years.

Bioage Labs Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: BIOA
CUSIP: 09072Q
Website: bioagelabs.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BIOA Technical Analysis vs Fundamental Analysis

Sell
41
Bioage Labs (BIOA) is a Sell

Is Bioage Labs a Buy or a Sell?

  • Bioage Labs stock is rated a Sell
    The current Bioage Labs [BIOA] share price is $19.51. The Score for BIOA is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.